Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Yersinia enterocoliticaSerogroup O:9 Strain Monoclonal Antibody

Cat. No.VD11Y644

Product TypeVeterinary Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for the Yersinia enterocoliticaserogroup O:9 strain. It can be applied to IF to help researchers detect or develop diagnosis assays of Yersinia enterocoliticaserogroup O:9 strain infection.

Specifications

Application IF
Clonality Monoclonal Antibody
Classification Primary Antibody
Clone N29Y82
Host Mouse
Target Species Bacteria
Species Reactivity Bacteria
Specificity Yersinia enterocoliticaSerogroup O:9 Strain
Isotype IgG3
Immunogen Inactive whole-cell Yersinia enterocoliticaserogroup O:9 strain.
Purification Protein A purified
Conjugation Unconjugated
Preservative and Stabilizer 0.5% BSA, 0.09% Sodium azide (NaN3)
Buffer Phosphate buffered saline
Physical State Liquid

Target Information

Yersinia enterocoliticaSerogroup O:9 is a bacterial strain that falls within the Yersinia genus. This specific strain is noteworthy for its impact on sensitive animals, particularly its pathogenic effects on humans and animals alike. In sensitive animals, such as rodents and certain livestock, Yersinia enterocoliticainfections can lead to enteric diseases characterized by symptoms like diarrhea, abdominal pain, and fever.

Target Yersinia enterocoliticaSerogroup O:9 Strain
Taxonomy ID 34055

Shipping and Storage

This product is shipped with dry ice. Store at 4°C on receipt (up to 12 months). DO NOT FREEZE.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Huang, Jing, et al. "Application of an O-linked glycosylation system in Yersinia enterocolitica serotype O: 9 to generate a new candidate vaccine against Brucella abortus." Microorganisms 8.3 (2020): 436.
Inquiry Basket